EMA validates Pfizer and Valneva’s Lyme disease vaccine

In the VALOR clinical trial, PF-07307405 showed efficacy of over 70% in preventing Lyme disease. Credit: MrWinn / Shutterstock.com.



  • EMA Pfizer Valneva